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sub-Saharan Africa, including Kenya.7 This study there-
fore sought to assess whether the frequency of TB in 
patients with diabetes would also have changed dur-
ing that time. There is also a well-known association 
between tobacco smoking and TB,8 and in addition, 
smoking is a risk factor for co-morbidities in patients 
with DM. There is thus a knowledge gap on the cur-
rent frequency of TB in patients with DM in the pres-
ence of HIV infection and tobacco smoking in sub-
Saharan Africa.
Given this gap and the large cohort of patients with 
DM treated in our clinics, we set out to determine the 
proportion of these patients with 1) a history of TB, 
2) HIV infection and 3) tobacco smoking. 
METHODS
Design
This was a descriptive study using routinely collected 
patient data from records in three out-patient diabetes 
clinics in Western Kenya.
Setting
This study was performed in a region with a high prev-
alence of HIV and TB. A recent rise in diabetes cases 
led to the establishment of diabetes clinics to care for 
these patients.9 The study included all the patients in 
the diabetes clinics in three hospitals in Western Kenya: 
Moi Teaching and Referral Hospital (MTRH) and two 
associated district hospitals, Webuye District Hospital 
(WDH) and Kitale District Hospital (KDH). MTRH is 
the second largest referral hospital in Kenya and serves 
the western region of Kenya. It serves both the ur-
ban population of Eldoret town, in which it is located, 
and the rural population of the surrounding region, as 
well as referral cases. WDH serves primarily a rural ag-
ricultural population, while KDH serves a peri-urban 
population. 
Diabetes management 
Patients in the three DM clinics were referred for dia-
betes care from a variety of sources: medical wards, 
medical out-patient clinics, health centers, dispensa-
ries and community health workers. Clinical care was 
standardized across the three clinics. A standardized 
initial encounter form captured relevant informa-
tion on enrollment: clinical, demographic, social and 
economic, including birth date, history of TB, HIV, 
cardiovascular disease and smoking. Standardized re-
turn visit forms were used during follow-up clinic vis-
its to document vital signs, weight, height, random 
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Setting: Diabetes clinics in three hospitals in Western 
Kenya: Moi Teaching and Referral Hospital and two as-
sociated district hospitals. 
Objective: To determine the proportion of diabetes pa-
tients with a history of tuberculosis (    TB), human immuno-
deficiency virus (HIV    ) infection and tobacco smoking. 
Design: A descriptive study using routinely collected 
data from patient records in the three diabetes clinics. 
Results: Of 1376 patients analyzed, 750 (55%) were fe-
male. The mean age of the patients in the clinics was 
53.5 years (95%CI 52.2–54.8), with an average duration 
of diabetes of 8.1 years (95%CI 7.6–8.7). Of all patients, 
5.6% reported a history of TB, similar to the frequency 
about 20 years earlier (1990) in Tanzania. Only 30% of 
the patients reported knowing their HIV status; 6% were 
HIV-positive. A history of tobacco smoking was reported 
by 3.8% of the patients.
Conclusion: The HIV epidemic does not seem to have 
significantly changed the relationship between TB and di-
abetes mellitus (DM) in this cohort of diabetes patients. 
The frequency of HIV and TB in this special population 
was comparable to that in the general population, and 
only a small proportion of patients reported a history of 
tobacco smoking.
I
n three diabetes clinics in Western Kenya, a number 
of patients reported having a cough. Cough can be 
due to heart failure, chest infections, or the adverse ef-
fect of medications (angiotensin converting enzyme 
inhibitors) used in the management of diabetes melli-
tus (DM). More importantly, cough can be a marker 
for pulmonary tuberculosis (TB), a disease that is com-
mon in Kenya.1
There is a strong association between TB and DM, 
with an estimated relative risk of 3.1 (95% conﬁ  dence 
interval [CI] 2.3–4.3) in one systematic review.2 Few 
of the studies in the review were carried out in low-
i  ncome countries, and none in Africa. This raises un-
certainties about the strength of the DM-TB associa-
tion in these settings, and critical questions remain 
unanswered.3 In sub-Saharan Africa, there have only 
been three studies on the co-morbidity of DM and TB. 
All were performed in Tanzania: two in 1990, one of 
which evaluated TB in patients with DM4 and the 
other DM in patients with TB;5 and the third in 2011, 
which evaluated DM in patients with TB.6
The human immunodeﬁ   ciency virus (HIV) epi-
demic that emerged in the late 1980s signiﬁ  cantly in-
creased the overall incidence of TB in countries in 
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blood sugar/fasting blood sugar, glycated hemoglobin 
(HbA1c), symptoms, clinical ﬁ   ndings and medica-
tions prescribed during the visit. At the end of the pa-
tient encounter, the data were entered into an Access 
(Microsoft Corp, Redmond, WA, USA) database by 
trained staff.
Participants 
The participants in this study were all patients with 
DM enrolled in the three clinics from January 2007 to 
February 2011, for whom information was available 
from the diabetes databases at the DM clinics. 
Variables
A TB case was deﬁ  ned as a patient who had TB re-
corded in the DM clinic register, based on self-report. 
From these patients, we identiﬁ  ed those in whom TB 
was diagnosed at or after the diagnosis of DM. HIV 
status was based on self-report as recorded in the regis-
ter. A smoker was deﬁ  ned as a patient who reported 
ever having smoked any form of tobacco.
Data collection
Data from the Microsoft Access database were col-
lected by the data manager. Variables included: age, 
sex, history of tuberculosis, date/year of DM diagnosis, 
HIV status and smoking history. Data were double-
entered into EpiData (EpiData Association, Odense, 
Denmark) and validated. 
Analysis
Data analysis using EpiData software included t-test, 
χ2 test or Fisher’s exact test; P < 0.05 was considered 
statistically signiﬁ  cant. 
Ethics approval
The study was approved by the Moi Teaching and Re-
ferral Hospital/Moi University School of Medicine In-
stitutional Research and Ethics Committee and the 
Ethics Advisory Group of the International Union 
Against Tuberculosis and Lung Disease, Paris, France.
RESULTS
Of 1519 patient records extracted from the database, 
143 (9%) were excluded due to missing data. Data for 
1376 patients were analyzed, of whom 750 (55%) were 
female. The mean age of the patients was 53.5 years 
(95%CI 52.2–54.8), with an average duration of diabe-
tes of 8.1 years (95%CI 7.6–8.7). The mean body mass 
index (BMI) was 26.8 (95%CI 26.3–27.3). At least one 
HbA1c result was available for 655 (48%) patients (av-
erage 10.5%, 95%CI 10.2–10.8), of whom 100 (15%) 
had HbA1c < 7%. Of the 1376 patients, 652 (47%) 
were on oral hypoglycemic agents and 495 (36%) on 
insulin. The remaining 229 patients (17%) had no 
treatment recorded in their charts, perhaps because 
they were not on treatment, or because it was omitted 
from their records. As this was a retrospective study, 
we were unable to determine the reasons. 
Of the 77 (5.6%) patients who reported a history 
of TB, 44 were diagnosed with TB after being diag-
nosed with DM. The only difference between patients 
with and those without TB was that a higher propor-
tion of men (61%) than women (44%) had TB. There 
was no difference based on age, BMI, history of to-
bacco smoking or alcohol intake, type of diabetes 
medication or HbA1c level.
Only 414 (30%) patients reported knowing their 
HIV status; of these, 25 (6%) were HIV-positive. Of 
the 44 patients who were diagnosed with TB after DM, 
29 knew their HIV status; 5 (17%) were HIV-positive.
Fifty-two (3.8%) patients reported a history of to-
bacco smoking; only one of these had a past history 
of TB. 
DISCUSSION
This is the ﬁ  rst study in sub-Saharan Africa in 22 years 
to describe TB in diabetes patients. In addition, it re-
ﬂ  ects the emergence of DM clinics in response to a 
rising tide of DM and the presence of important co-
morbidities, including TB (DM is a risk factor for TB), 
HIV (which is a prevalent health risk in these commu-
nities and a promoter of TB), and smoking. In this 
study in Western Kenya, 5.6% of the patients reported 
a history of TB, and only 30% of the patients knew 
their HIV status. In addition, we found a very low rate 
of tobacco smoking.
This study revealed new information about diabe-
tes management in Kenya. Patients had been on treat-
ment for an average of 8 years, with HbA1c levels and 
BMI remaining higher than accepted international tar-
gets.10 However, these results are similar to those in 
many other countries in sub-Saharan Africa, where pa-
tients receive less than optimal care for their diabe-
tes.11,12 Despite the generally poor diabetes control in 
this population, a third of our patients were on insulin 
therapy, and our clinics used HbA1c testing, indicat-
ing reasonable access to diabetes management tools.
In a setting with high HIV and TB prevalence, the 
co-morbidity of these infectious diseases in patients 
with DM is to be expected. Only a small proportion of 
this diabetic population had a past history of TB. 
These results may not reﬂ  ect the true burden of TB in 
DM due to the retrospective nature of the study and 
the stigma associated with TB in the past due to its as-
sociation with HIV. In 1990, Swai et al. showed a 5.4% 
incidence of TB in Tanzania in a 7-year follow-up of 
1250 diabetic patients.4 Even though the true rate of 
TB might be higher, TB should be considered as an im-
portant co-morbidity of DM in this setting. The low 
rate of TB in this study does not support a policy of 
routine laboratory screening for TB, although patients 
presenting with symptoms compatible with TB should 
be investigated.
HIV is still an important public health issue in 
K  enya. In our study, the proportion of patients who 
knew their HIV status, and were HIV-positive, was com-
parable to rates in the general Kenyan population.13 
However, the proportion of patients with a history of 
TB and who were HIV-positive was substantially higher 
(17%). This higher proportion could have been due to 
the fact that TB patients were more likely to have been 
tested for HIV at the TB clinics.14 Patients are not sys-
tematically offered HIV testing in DM clinics, and only 
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30% of the DM patients studied knew their HIV status. The DM 
clinic patients had an average age of >50 years, and their only 
contact with the health care system may have been the DM clinic, 
where HIV was not routinely tested. HIV screening, one of the 
principal strategies for the control of the HIV epidemic, should 
therefore be offered to all patients in the diabetes clinics and 
other chronic disease clinics in our setting.
Tobacco smoking has been recognized as a major health prob-
lem in many settings worldwide. In 2004, a tobacco survey showed 
that 13.7% of adults in Kenya aged >18 years reported smoking 
tobacco (unpublished report). In this study, a relatively small pro-
portion of patients, 3.8%, were tobacco smokers. We suggest this 
could be due to the cost of tobacco products, which may have 
been a deterrent to smoking among patients with many ﬁ  nancial 
obligations and limited resources. Furthermore, many patients in 
the rural setting chew and sniff tobacco, and no data on these 
forms of tobacco use were collected in the clinics.
The strengths of this study are that it is a cross-sectional look 
at the co-morbidity of TB, HIV and tobacco smoking in a new, 
emerging set of clinics caring for patients with DM. The study 
sample was large, and included all patients registered in the clin-
ics over a 4-year period. It was also carried out under routine pro-
gram conditions, and thus likely reﬂ  ected the situation in chronic 
disease clinics in Western Kenya. Finally, the study adhered to 
Strengthening the Reporting of Observational Studies in Epidemi-
ology (STROBE) guidelines.15
The study had several limitations. One was the use of routine 
clinic data, which may have been inaccurate or had missing ele-
ments. However, only a small percentage of the clinic charts (9%) 
had to be excluded due to missing data. In addition, the study re-
lied on recall of history of TB and HIV status, which may have 
been inaccurate. Although it is highly unlikely for a patient to 
forget a previous episode of TB, there could have been reporting 
bias (denial) due to associated stigma. TB has been associated with 
HIV in many clinical settings, and patients with DM may have 
declined to disclose a history of TB due to its association with 
HIV. In particular, patients could have inaccurately recalled the 
timing of diagnosis of TB and the timing of the onset of their dia-
betes. This could have led to an underestimation of the burden of 
TB attributable to DM. The poor diabetes control in this popula-
tion could explain the failure to detect an association between TB 
and poor DM control, i.e., there were insufﬁ  cient patients with 
good control to act as a comparison group for poor DM control as 
a risk factor for TB.
CONCLUSION
The rising prevalence of patients with DM in communities with 
a high prevalence of TB and HIV is bound to increase the co-
morbidity of these diseases and present new challenges for clini-
cians in sub-Saharan Africa. Further prospective studies are there-
fore necessary to better describe the co-morbidity between the 
two common infectious diseases, HIV and TB, with DM in our 
population. The frequency of HIV and TB in this cohort was com-
parable to that in the general population, with only a small pro-
portion of patients reporting a history of tobacco smoking.
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Contexte  :    Les polycliniques du diabète dans trois hôpitaux de l’Ouest 
du Kenya : Moi Teaching et Referral Hospital et deux hôpitaux de dis-
trict associés.
Objectif  :  Déterminer la proportion de patients diabétiques ayant des 
antécédents de tuberculose (TB), d’infection par le virus de l’immuno-
déficience humaine (VIH) et de tabagisme.
Schéma  :    Etude descriptive utilisant les données colligées en routine 
dans les dossiers des patients dans les trois polycliniques du diabète.
Résultats  :  On a analysé 1376 patients, parmi lesquelles 750 femmes 
(55%). L’âge moyen des patients dans les polycliniques a été de 
53,5 années (IC95% 52,2–54,8), avec une durée moyenne du diabète 
de 8,1 années (7,6–8,7). Sur l’ensemble des patients, 5,6% ont si-
gnalé des antécédents de TB, fréquence similaire à celle existant 20 ans 
plus tôt (1990) en Tanzanie. Seulement 30% des patients ont signalé 
connaître leur statut VIH et 6% ont été séropositifs pour le VIH. Des 
antécédents de tabagisme ont été signalés par 3,8% des patients.
Conclusion  :    L’épidémie de VIH ne semble pas avoir modifié de ma-
nière significative les relations entre la TB et le diabète dans cette co-
horte de patients diabétiques. La fréquence du VIH et de la TB dans 
cette population spécifique est comparable à celle observée dans la 
population générale ; une proportion faible seulement de patients 
signale des antécédents de tabagisme.
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Marco de referencia: Los consultorios de atención de la diabetes 
en los siguientes hospitales de Kenia occidental: el Moi Teaching and 
Referral Hospital y dos hospitales distritales adjuntos. 
Objetivo: Determinar la proporción de pacientes diabéticos que 
presentaban antecedentes de tuberculosis (TB), infección por el vi-
rus de la inmunodeficiencia humana (VIH) o tabaquismo. 
Método: Un estudio descriptivo a partir de los datos recogidos de 
manera sistemática en las historias clínicas de los pacientes en tres 
consultorios de atención de la diabetes. 
Resultados: Se analizaron las historias clínicas de 1376 pacientes, 
de los cuales 750 fueron de sexo femenino (55%). El promedio de 
edad de los pacientes fue de 53,5 años (IC95% 52,2–54,8) y el pro-
medio de evolución de la diabetes fue 8,1 años (IC95% 7,6–8,7). El 
5,6% de los pacientes refirió antecedentes de TB, lo cual corre-
sponde a la frecuencia registrada 20 años atrás (1990) en Tanzania. 
Solo el 30% de los pacientes refirió conocer su estado con respecto al 
VIH y el 6% presentaba un examen serológico positivo. Un 3,8% de 
pacientes refirió antecedentes de tabaquismo.
Conclusión: La epidemia de infección por el VIH no parece haber 
cambiado de manera significativa la relación entre la TB y la diabetes 
sacarina en esta cohorte de pacientes diabéticos. La frecuencia de in-
fección por el VIH y de TB en esta población específica fue equiva-
lente a la frecuencia en la población general y solo una pequeña pro-
porción de pacientes refirió antecedentes de tabaquismo.